Prices on branded drugs increased 3.9% in Q1 2006(registration required), the largest increase in six years. Coincidentally, the Medicare Part D drug coverage program went into effect 1/1/2006. Part D has resulted in somewhere around ten million new customers for insurers, who will now pay 4.7% more for Lipitor and 13.3% more for Ambien.
In terms of dollars, AARP calculates the average senior’s costs will increase by almost $20 per month, as the Part D providers are passing the cost increases along to their subscribers.
There has been the usual rash of outraged protests from various mouthpieces for big pharma, all of which are either disingenuous, outrageously self-serving, misleading, or poor attempts at deflecting blame towards insurers et al.
So what happens when pharma decides to increase prices?
Well, the mass media starts looking at what the Veterans Administration pays for drugs. Compared to the VA, the only federal entity allowed to negotiate prices, Part D prices are now 46% higher on average.
Here are a couple examples, quoted from the Families USA report.
“For Zocor (20 mg), the lowest VA price for a year’s treatment was $127.44, while the lowest Part D plan price was $1,275.36, a difference of $1,147.92 or 901 percent.
For Fosamax (70 mg), the lowest VA price for a year’s treatment was $265.32, while the lowest Part D plan price was $727.92, a difference of $462.60 or 174 percent.”
So here we have big government, in the form of the VA, delivering prices that are about half of what private industry can obtain. While that’s kind of interesting, it gets way more than “kind of” interesting when you consider that Part D has added $8 trillion to the nation’s long term debt. That’s a quarter of the entire Medicare deficit…
Tell me again how privatizing health care for seniors is a good deal for taxpayers, seniors, and the country?